Holen Sie sich die Stockscreener-App
0.81
28.95%
-0.33
Vorhandelsmarkt:
.81
Schlusskurs vom Vortag:
$1.14
Offen:
$1.51
24-Stunden-Volumen:
47.68M
Relative Volume:
16.93
Marktkapitalisierung:
$6.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.74M
KGV:
-0.3951
EPS:
-2.05
Netto-Cashflow:
$-8.25M
1W Leistung:
-55.69%
1M Leistung:
-86.19%
6M Leistung:
-97.02%
1J Leistung:
-96.10%
1-Tages-Spanne:
$0.74
$2.13
1-Wochen-Bereich:
$0.74
$2.23
52-Wochen-Spanne:
$0.74
$99.00
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.81 | 6.30M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
579.65 | 206.74B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
242.42 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.57 | 45.29B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
240.46 | 35.33B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
331.04 | 24.01B | 2.88B | 499.60M | 321.60M | 6.74 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
Glucotrack reports success in first human glucose monitor trial By Investing.com - Investing.com Canada
GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
Market cap of GlucoTrack Inc [GCTK] reaches 8.86M – now what? - The DBT News
Glucotrack, Inc. Announces Pricing Of $3.0 Million Public Offering -February 04, 2025 at 01:59 pm EST - Marketscreener.com
Glucotrack hits trial success for direct blood measuring CGM - Yahoo! Voices
Glucotrack sets terms for $3 million public stock offering - Investing.com
GlucoTrack Prices $3 Million Public Offering; Shares Fall -February 04, 2025 at 12:48 pm EST - Marketscreener.com
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - The Manila Times
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle – market - HPBL
Diabetes Tech Pioneer Glucotrack Raises Fresh Capital: Key Details of $3M Share Offering Revealed - StockTitan
Glucotrack completes first-in-human continuous blood glucose monitor implant study - Mass Device
Glucotrack stock soars on completion of first human clinical study of CBGM - Seeking Alpha
GlucoTrack Announces Reverse Stock Split and Clinical Study Success - TipRanks
Glucotrack completes first-in-human CGM implant study - Drug Delivery Business News
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - The Manila Times
Glucotrack reports success in first human glucose monitor trial - Investing.com
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous - The Bakersfield Californian
Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - StockTitan
GlucoTrack Inc: -98.71% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle
Glucotrack, Inc. Announces 1-for-20 Reverse Stock Split - Defense World
GCTK Stock Plummets to 52-Week Low of $0.06 Amid Market Turbulence - MSN
GlucoTrack Announces Resignation of Chief Financial Officer and Appointment of Peter Wulff as Replacement**WASHINGTON, D.C. 2025 – GlucoTrack, Inc. (NASDAQ: GCTK) recently disclosed on January 27, 2025, that James Cardwell, the Chief Financial - Defense World
Glucotrack announces 1-for-20 reverse stock split - Investing.com India
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
GlucoTrack Announces 1-for-20 Reverse Stock Split - TipRanks
Glucotrack to execute 1-for-20 reverse stock split - MSN
GlucoTrack, Inc. Announces Chief Financial Officer Changes -January 29, 2025 at 09:00 am EST - Marketscreener.com
Glucotrack announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - StockTitan
Glucotrack Appoints Peter C. Wulff as CFO - citybiz
GlucoTrack Appoints Peter Wulff as CFO -January 29, 2025 at 11:41 am EST - Marketscreener.com
GlucoTrack Strengthens Leadership with New CFO Appointment - TipRanks
35-Year MedTech Finance Veteran Joins Glucose Monitor Innovator as New CFO - StockTitan
How Is The Market Feeling About GlucoTrack? - Benzinga
Headwater Exploration (OTCMKTS:CDDRF) Trading 3.1% Higher – Should You Buy? - Defense World
Cuisine Solutions (OTCMKTS:CUSI) Shares Down 0.5% – Here’s Why - Defense World
StockNews.com Upgrades Park Aerospace (NYSE:PKE) to Buy - Defense World
Interfor (TSE:IFP) Given New C$26.00 Price Target at Raymond James - Defense World
Li Ning (OTCMKTS:LNNGF) Trading 3.3% Higher – Here’s What Happened - Defense World
John Bean Technologies (NYSE:JBT) Now Covered by StockNews.com - Defense World
Old Second Bancorp Declares Quarterly Cash Dividend On January 21, 2025, Old Second Bancorp, Inc. (NASDAQ: OSBC) announced through a Form 8-K filing that its Board of Directors has approved a cash dividend of $0.06 per share. The dividend is set to - Defense World
Jupiter Wellness (NASDAQ:JUPW) Reports Regulation FD Disclosure Concerning Safety Shot, Inc. - Defense World
Ark Restaurants (NASDAQ:ARKR) Coverage Initiated by Analysts at StockNews.com - Defense World
NextSource Materials (OTCMKTS:NSRCF) Stock Price Up 7.1% – Time to Buy? - Defense World
FIBRA Terrafina (OTCMKTS:CBAOF) Trading 13% Higher – Should You Buy? - Defense World
Tabcorp (OTCMKTS:TACBY) Shares Down 12% – Here’s What Happened - Defense World
Telefónica (OTCMKTS:TEFOF) Trading Down 7.3% – What’s Next? - Defense World
BEO Bancorp (OTCMKTS:BEOB) Stock Price Down 1.2% – Here’s What Happened - Defense World
Vicarious Surgical Inc. Enters into Consulting Agreement with Former CFOWASHINGTON, D.C. 20549 — On January 17, 2025, Vicarious Surgical Inc. (NYSE: RBOT) filed a current report on Form 8-K with the Securities and Exchange Commission, detailing th - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
GlucoTrack Achieves ISO13485:2016 Certification for CBGM - TipRanks
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):